Martha Carnes - Core Laboratories Executive

CLB
 Stock
  

USD 16.57  0.12  0.73%   

  Executive
Ms. Martha Z. Carnes serves as Independent Member of the Board of Supervisory Directors of Core Laboratories N.V. She retired from PricewaterhouseCoopers LLP in June 2016, where she had a 34 year career with the firm. She was an Assurance Partner serving large, publicly traded companies in the energy industry. Ms. Carnes held a number of leadership positions with PwC including the Houston office Managing Partner. She also served as PwCs Energy and Mining leader for the United States where she led the firms energy and mining assurance, tax and advisory practices. In these roles, she was responsible for leading the design and execution of the market and sector strategies, business development, compensation, professional development, succession planning, and client satisfaction. As an Assurance Partner, Ms. Carnes had experience with capital markets activities and was the lead audit partner on some of the merger and acquisition transactions completed in the energy sector. Ms. Carnes also served as one of PwCs Risk Management Partners and was PwCs United States representative on the firms Global Communities Board. She is a member of the American Institute of Certified Public Accountants and the Texas Society of Certified Public Accountants. Ms. Carnes is the Chairman of the Governing Board of The Greater Houston Community Foundation, and has chaired their Compensation, Strategy, and Finance Administration Committees. She is also a member of the Board of Trustees at Texas Childrens Hospital where she serves on the Audit and Compliance Operations, Planning and Development and Risk Management and Insurance Committees. Her financial expertise and experience in working with and auditing public companies in the energy industry, and her operational experience at PwC, a professional services firm, allow her to provide important insight to the Company.
Age: 60  Executive Since 2019      
31 20 420 3191  https://www.corelab.com

Martha Carnes Latest Insider Activity

Tracking and analyzing the buying and selling activities of Martha Carnes against Core Laboratories stock is an integral part of due diligence when investing in Core Laboratories. Martha Carnes insider activity provides valuable insight into whether Core Laboratories is net buyers or sellers over its current business cycle. Note, Core Laboratories insiders must abide by specific rules, including filing SEC forms every time they buy or sell Core Laboratories'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Core Laboratories Management Efficiency

Core Laboratories has Return on Asset of 3.53 % which means that on every $100 spent on asset, it made $3.53 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 5.55 %, implying that it generated $5.55 on every 100 dollars invested. Core Laboratories management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 244.22 M in debt with debt to equity (D/E) ratio of 1.41, which is OK given its current industry classification. Core Laboratories has a current ratio of 2.04, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Core Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Core Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Core Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Core Laboratories to invest in growth at high rates of return. When we think about Core Laboratories' use of debt, we should always consider it together with cash and equity.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States. Core Laboratories NV (CLB) is traded on New York Stock Exchange in USA and employs 3,600 people.

Core Laboratories Leadership Team

Elected by the shareholders, the Core Laboratories' board of directors comprises two types of representatives: Core Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Core Laboratories. The board's role is to monitor Core Laboratories' management team and ensure that shareholders' interests are well served. Core Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Core Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
Tahera Khan, Vice President Human Resources
Gwendolyn Schreffler, Senior Vice President, Corporate Development and Investor Relations
Lawrence Bruno, Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer
Monique Eeuwijk, Non-Executive Independent Member of the Supervisory Board
D Ogren, Member of the Supervisory Board
Michael Flecker, Vice President Production Enhancement
Christopher Hill, Chief Financial Officer, Senior Vice President
Alastair Crombie, Vice President Reservoir Description
Mark Elvig, Senior Vice President, Secretary, and General Counsel
Harvey Klingensmith, Non-Executive Independent Member of the Supervisory Board
Michael Straughen, Non-Executive Independent Member of the Supervisory Board
John Ogren, Member of the Supervisory Board
Charles Dunlap, Independent Member of the Board of Supervisory Directors
Monty Davis, COO and Sr. VP
David Hume, Vice President Reservoir Description
J Dumas, Vice President Business Development
Martha Carnes, Presiding Non-Executive Lead Independent Member of the Supervisory Board
Richard Bergmark, CFO, Executive VP and Supervisory Director
Kevin Daniels, Vice President, Chief Accounting Officer
James Gresham, Senior Vice President Business Development
David Demshur, Independent Chairman of the Board of Supervisory Directors and Chief Executive Officer
Kwaku Temeng, Non-Executive Independent Member of the Supervisory Board
Michael Kearney, Independent Supervisory Director
Peter Boks, Vice President Reservoir Description
Gregory Barnett, Non-Executive Independent Member of the Supervisory Board
Chris Hill, Chief Accounting Officer and VP
Margaret Kempen, Independent Member of the Board of Supervisory Directors
Lucia Geuns, Independent Member of the Board of Supervisory Directors
Jeffrey West, Vice President Production Enhancement
Mark Tattoli, Senior Vice President General Counsel, Secretary
Dumas, Vice President Business Development
Gwendolyn Gresham, Senior Vice President Corporate Development and Investor Relations
Jan Sodderland, Independent Member of the Board of Supervisory Directors

Core Laboratories Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Core Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Core Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Core Laboratories' short interest history, or implied volatility extrapolated from Core Laboratories options trading.

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Laboratories

+0.75HALHalliburton Upward RallyPairCorr
The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.